BURLINGTON, N.C. --(BUSINESS WIRE)--Apr. 28, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, today announced results for the first quarter ended March 31, 2022 , and updated full-year guidance.
When the COVID-19 pandemic started, we had a singular enemy: the SARS-CoV-2 virus. However, now it seems that there are multiple enemies, with the emergence of variants like Delta and Omicron. How did this happen?
Join us in celebrating National Military Appreciation Month as we recognize the services of our veterans, reservists and active duty members and their families.
BURLINGTON, N.C. --(BUSINESS WIRE)--Apr. 22, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, today announced the launch of Getlabs for Labcorp, an innovative health care service that combines Labcorp’s diagnostic tests with Getlabs phlebotomy service to conveniently test consumers in the comfort of their own homes.
BURLINGTON, N.C. --(BUSINESS WIRE)--Apr. 19, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, is collaborating with Xcell Biosciences, Inc. (Xcellbio), a leading developer of cell and gene therapy technologies, to advance critical work that helps clients effectively bring innovative cell and gene therapies to market.
